NEVVI Medicare utilization intelligence

← back

Provider profile

KIM, THOMAS MD

Dermatology · NPI 1033179072 · WESTLAKE VILLAGE, CA

1
Groups
35
Codes · 2024
8,002
Disclosed services

KIM, THOMAS is a Dermatology in WESTLAKE VILLAGE, CA, a member of 1 medical group, who billed 35 distinct codes to Medicare Part B in 2024.

Groups: INTEGRATED DERMATOLOGY OF WESTLAKE VILLAGE PC (WESTLAKE VILLAGE, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

8,002
disclosed services
35
codes billed to Medicare Part B
Prior year · CY2023 6,911 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
88305 Pathology examination of tissue using a microscope, intermediate complexity premiumpremium premiumpremium
17000 Destruction of precancer skin growth, 1 growth premiumpremium premiumpremium
11102 Biopsy of related skin growth, first growth premiumpremium premiumpremium
17004 Destruction of precancer skin growth, 15 or more growths premiumpremium premiumpremium
17110 Destruction of skin growth, 1-14 growths premiumpremium premiumpremium
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more premiumpremium premiumpremium
11103 Biopsy of related skin growth, each additional growth premiumpremium premiumpremium
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks premiumpremium premiumpremium
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm premiumpremium premiumpremium
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) premiumpremium premiumpremium
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks premiumpremium premiumpremium
96573 Application of light by qualified health care professional to destroy precancer skin growth premiumpremium premiumpremium
17313 Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks premiumpremium premiumpremium
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm premiumpremium premiumpremium
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more premiumpremium premiumpremium
11900 Injection into skin growth, 1-7 growths premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
12031 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less premiumpremium premiumpremium
17314 Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks premiumpremium premiumpremium
10060 Simple or single drainage of skin abscess premiumpremium premiumpremium
69100 Biopsy of ear premiumpremium premiumpremium
12042 Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm premiumpremium premiumpremium
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm premiumpremium premiumpremium
12051 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less premiumpremium premiumpremium
88304 Pathology examination of tissue using a microscope, moderately low complexity premiumpremium premiumpremium
11401 Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm premiumpremium premiumpremium
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.